Menu
Back to Archived Journals » Research and Reports in Endocrine Disorders » Volume 2
Optimal management of Cushing syndrome
Authors Durán-Pérez Edgar G. EGD, Moreno-Loza OT, Carrasco-Tabón G, Segovia Palomo A
Received 4 March 2012
Accepted for publication 10 April 2012
Published 21 June 2012 Volume 2012:2 Pages 19—30
DOI https://doi.org/10.2147/RRED.S25345
Review by Single anonymous peer review
Peer reviewer comments 3
Edgar G Durán-Pérez,1 Oscar T Moreno-Loza,2 German Carrasco-Tobón,3 Segovia-Palomo Antonio3
1Division of Endocrinology, Hospital General de Saltillo, Saltillo, Coahuila, 2Division of Endocrinology, Hospital de Alta Especialidad, ISSSTE, Tultitlán, 3Endocrinology Deparment, Hospital General de México, México Distrito Federal, México
Abstract: Cushing syndrome (CS) caused by endogenous hypercortisolism is a diagnostic challenge. The most common cause is Cushing disease. Surgical treatment is the first-line therapy for Cushing disease. However, due to the often clinical instability of the patient's condition, which needs acute treatment of hypercortisolism or inoperable tumors, initial surgery is often not possible. It is therefore important to provide appropriate initial medical treatment. Following surgery, the patient needs to be evaluated and confirmed for disease resolution based on standard criteria, and treated with appropriate supportive measures for the rest of life if necessary. This article reviews the current data and treatment options for Cushing syndrome and proposes a therapeutic algorithm for its optimal management.
Keywords: cushing syndrome, cushing disease, hypercortisolism
© 2012 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.